Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
19,807,471
-
Total 13F shares
-
8,990,036
-
Share change
-
+7,880,106
-
Total reported value
-
$89,803,971
-
Price per share
-
$9.96
-
Number of holders
-
20
-
Value change
-
+$78,749,069
-
Number of buys
-
18
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) as of Q4 2024
As of 31 Dec 2024,
Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,990,036 shares.
The largest 10 holders included
AQR Arbitrage LLC, TORONTO DOMINION BANK, Boussard & Gavaudan Investment Management LLP, Decagon Asset Management LLP, Shaolin Capital Management LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), HIGHBRIDGE CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, GRITSTONE ASSET MANAGEMENT LLC, and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.